Evidence map›Paper›PMID 34643665›Full record

ArticleInvestigative ophthalmology & visual science2021

Influence of Sex on Neuroretinal Degeneration: Six-Month Follow-Up in Rats With Chronic Glaucoma.

Maria J Rodrigo, Teresa Martinez-Rincon, Manuel Subias, Silvia Mendez-Martinez, Luis E Pablo, Vicente Polo, Alba Aragon-Navas, David Garcia-Herranz, Julian García Feijoo, Irene Bravo Osuna and 2 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Maria J RodrigoDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
Teresa Martinez-RinconDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
Manuel SubiasDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
Silvia Mendez-MartinezDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
Luis E PabloDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
Vicente PoloDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
Alba Aragon-NavasOphthalmology Innovation, Therapy and Pharmaceutical Development (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.
David Garcia-HerranzOphthalmology Innovation, Therapy and Pharmaceutical Development (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.
Julian García FeijooNational Ocular Pathology Network (OFTARED), Carlos III Health Institute, Madrid, Spain.
Irene Bravo OsunaNational Ocular Pathology Network (OFTARED), Carlos III Health Institute, Madrid, Spain.
Rocio Herrero-VanrellNational Ocular Pathology Network (OFTARED), Carlos III Health Institute, Madrid, Spain.
Elena Garcia-MartinDepartment of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
Universidad de Zaragoza · ESUniversidad Complutense de Madrid · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate differences by sex in the neuroretina of rats with chronic glaucoma over 24 weeks of follow-up, and to assess by sex the influence on neurodegeneration of different methods of inducing ocular hypertension. Methods: Forty-six Long-Evans rats-18 males and 28 females-with induced chronic glaucoma were analyzed. Glaucoma was achieved via 2 models: repeatedly sclerosing the episcleral veins (9 male/14 female) or by injecting poly(lactic-co-glycolic acid) microspheres measuring 20 to 10 µm (Ms20/10) into the anterior chamber (9 male/14 female). The IOP was measured weekly by tonometer; neuroretinal function was recorded by dark/light-adapted electroretinography at baseline and weeks 12 and 24; and structure was analyzed by optical coherence tomography using the retina posterior pole, retinal nerve fiber layer and ganglion cell layer protocols at baseline and weeks 8, 12, 18, and 24. Results: Males showed statistically significant (P < 0.05) higher IOP in both chronic glaucoma models, and greater differences were found in the episcleral model at earlier stages. Males with episclerally induced glaucoma showed a statistically higher increase in retinal thickness in optical coherence tomography recordings than females and also when comparing Ms20/10 at 12 weeks. Males showed a higher percentage of retinal nerve fiber layer thickness loss in both models. Ganglion cell layer thickness loss was only detected in the Ms20/10 model. Males exhibited worse dark/light-adapted functionality in chronic glaucoma models, which worsened in the episcleral sclerosis model at 12 weeks, than females. Conclusions: Female rats with chronic glaucoma experienced lower IOP and structural loss and better neuroretinal functionality than males. Sex and the ocular hypertension-inducing method influenced neuroretinal degeneration.

Indexed as

AnimalsDisease Models, AnimalDisease ProgressionElectroretinographyFemaleGlaucomaIntraocular PressureMaleNerve FibersRatsRats, Long-EvansRetinal DegenerationRetinal Ganglion CellsTime FactorsTomography, Optical Coherence

Identifiers

PMID34643665
PMCPMC8525827
OpenAlexW3205491431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.